دورية أكاديمية
Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study
| العنوان: | Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study |
|---|---|
| المؤلفون: | Adenis, AntoineAff1, IDs00280024046824_cor1, Ghiringhelli, François, Gauthier, Ludovic, Mazard, Thibault, Evesque, Ludovic, Evrard, AlexandreAff5, Aff6, Chalbos, Patrick, Moussion, Aurore, Gourgou, Sophie, Ychou, Marc |
| المصدر: | Cancer Chemotherapy and Pharmacology. :1-10 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 03445704 14320843 |
|---|---|
| DOI: | 10.1007/s00280-024-04682-4 |